{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-236933","form_type":"8-K","ticker":"CNTA","cik":"0001847903","company_name":"Centessa Pharmaceuticals plc","filed_at":"2026-05-22T20:15:48+00:00","discovered_at":"2026-05-22T20:18:00.297059+00:00","generated_at":"2026-05-22T21:07:49.925492+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"confidence":"high","headline":"HSR waiting period expires for Lilly's acquisition of Centessa; condition satisfied","bullets":["Hart-Scott-Rodino waiting period expired at 11:59 p.m. on May 21, 2026, clearing antitrust review.","Acquisition of Centessa by Eli Lilly announced March 31, 2026; remains subject to shareholder vote and court sanction.","Proxy statement filed May 7, 2026; shareholders urged to vote on the scheme of arrangement.","Closing requires approval by Centessa shareholders and sanction by High Court of Justice of England and Wales."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-236933","json":"https://secwatch.observer/filing/0001193125-26-236933.json","markdown":"https://secwatch.observer/filing/0001193125-26-236933.md","text":"https://secwatch.observer/filing/0001193125-26-236933.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526236933/0001193125-26-236933-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847903/000119312526236933/d156443d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T21:07:49.925492+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}